Yale scientists have made a significant breakthrough in understanding the aging process by identifying which treatments can slow down biological aging. Their study, published in Nature Medicine, analyzed 51 clinical studies and found that certain prescription medications and lifestyle changes can reduce biological age as measured by DNA-based blood tests.

The researchers, led by Raghav Sehgal, used advanced computer science techniques to investigate the biological mechanisms behind human aging and how scientists can measure those changes. They examined over 110 DNA methylation biomarkers, including 16 major epigenetic clocks, to determine which interventions were associated with reductions in biological age. The study found that combining regular physical activity with a healthy eating plan consistently reduced epigenetic age. Certain pharmaceutical treatments, such as metformin and semaglutide, also showed strong reductions in biological age markers. However, over-the-counter supplements and some medical procedures did not produce measurable reductions in epigenetic age. The researchers emphasized that changes in biological age markers do not necessarily mean people will live longer or avoid age-related diseases. However, their findings could help scientists evaluate anti-aging treatments more effectively and identify promising treatments earlier. The study's results also suggest that newer biological age clocks perform better than older versions and that people living with diseases experience larger changes in their aging biomarkers than healthy participants. The next step is to test these findings in larger, more diverse populations to determine how consistently different treatments influence biological aging across people with different health conditions and backgrounds. The improved blood tests could also dramatically shorten the time needed to evaluate potential anti-aging therapies.